Literature DB >> 9105776

Ketorolac induced acute reversible hearing loss in a patient maintained on CAPD.

T Otti, M Weindel, B Bastani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9105776

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN： 0301-0430            Impact factor:   0.975


× No keyword cloud information.
  4 in total

Review 1.  Impact of nonaspirin nonsteroidal anti-inflammatory agents and acetaminophen on sensorineural hearing loss: a systematic review.

Authors:  Meghann E Kyle; James C Wang; Jennifer J Shin
Journal:  Otolaryngol Head Neck Surg       Date:  2015-01-05       Impact factor: 3.497

Review 2.  Minimising the adverse effects of ketorolac.

Authors:  D I Reinhart
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

3.  Cumulative disease activity predicts incidental hearing impairment in patients with rheumatoid arthritis (RA).

Authors:  Virginia Pascual-Ramos; Irazú Contreras-Yáñez; Paula Rivera-Hoyos; Lorena Enríquez; Jaqueline Ramírez-Anguiano
Journal:  Clin Rheumatol       Date:  2014-01-18       Impact factor: 2.980

4.  Effects of acute administration of ketorolac on mammalian vestibular sensory evoked potentials.

Authors:  G Christopher Gaines; Timothy A Jones
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-01       Impact factor: 1.232
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.